Long-term opioids may not be best pain management option for all sickle cell patients

(Johns Hopkins Medicine) In a small study looking at pain assessments in adults with sickle cell disease, researchers at Johns Hopkins says overall, those treated long-term with opioids often fared worse in measures of pain, fatigue and curtailed daily activities than those not on long-term opioids.